JENNIFER MARGOPULOS-KELENSKE: Open Payments
NPI 1548339930 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,361 in 38 payments from 15 companies in 2025. Trend: 2023 $306 · 2024 $533 · 2025 $3,361
Travel & lodging: $2,291Food & beverage: $1,070
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 12 | $2,513 |
| Madrigal Pharmaceuticals | 4 | $220 |
| Enterra Medical, Inc. | 1 | $145 |
| ABBVIE INC. | 6 | $108 |
| Novo Nordisk Inc | 1 | $106 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $85 |
| Ipsen Biopharmaceuticals, Inc | 2 | $40 |
| Janssen Biotech, Inc. | 1 | $25 |
| Intercept Pharmaceuticals, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $21 |
Products named: Livdelzi, REZDIFFRA, Wegovy, ENTYVIO, CREON, TREMFYA, IQIRVO, SKYRIZI.
Industry payments across NC — which companies pay providers there.
